lysine acetylation has emerged as one of the major post-translational modifications, as indicated by its roles in chromatin remodeling, activation of transcription factors and, most recently, regulation of metabolic enzymes. Identification of acetylation sites in a protein is the first essential step for functional characterization of acetylation in physiological regulation. However, the study of the acetylome is hindered by the lack of suitable physical and biochemical properties of the acetyl group and existence of high-abundance acetylated histones in the cell, and needs a robust method to overcome these problems. Here we present protocols for (i) using chemically acetylated ovalbumin and synthetic acetylated peptide to generate a pan-acetyllysine antibody and a sitespecific antibody to lys288-acetylated argininosuccinate lyase, respectively; (ii) using subcellular fractionation to reduce highly abundant acetylated histones; and (iii) using acetyllysine antibody affinity purification and mass spectrometry to characterize acetylome of human liver tissue. the entire characterization procedure takes ~2-3 d to complete. Moreover, the acetylated lysine residue may be buried inside a protein and not accessible to antibody binding. These problems can be solved by trypsin digestion. The acetylated peptides generated by protease digestion are much smaller than a whole protein and can be immunoprecipitated by anti-acetyllysine even if the antibody has low affinity. Furthermore, acetylated lysine residues will be readily accessible to the antibody because digested peptides lack secondary structure. To avoid interference by highly abundant acetylated proteins such as histone, cell fractionation can be used to separate the nucleus from other organelles or cytosol.
IntroDuctIon
Protein lysine acetylation refers to post-translational addition of an acetyl group to the ε-amino group of the side chain of a lysine residue. This modification is different from N-terminal α-amino group acetylation with respect to the nature of modifying enzymes and physiological functions 1 . Multiple acetyltransferases and deacetylases are responsible for lysine acetylation, which has major roles in regulating various biological functions, whereas N-terminal acetylation often functions to stabilize proteins 1,2 . Internal lysine acetylation was discovered in histones in the early 1960s (refs. 3,4) , and rapid progress has been made in the field in the past one-and-a-half decades. Imbalance in histone acetylation has been found to change chromatin structure and to be associated with transcriptional dysregulation of genes that are involved in the control of proliferation, cell-cycle progression, differentiation and/or apoptosis 5, 6 . Nonhistone proteins, mainly nuclear transcription regulators such as p53 and E2F, have also been found to be acetylated, and their activities are regulated by acetylation [7] [8] [9] . Therefore, extensive studies have revealed that acetylation has a fundamental role in transcription regulation, by either altering chromatin structure through histone modification or modulating individual transcription factors or coregulators.
With more biological functions of acetylation being revealed, an easy and robust protocol for identifying acetylation will greatly benefit the field of protein acetylation. Detection of protein acetylation is challenging mainly because of the lack of usable physical and biochemical properties of the acetyl group. It is, however, possible to generate antibodies to acetylated lysine residues (anti-acetyllysine), and antibody affinity purification offers the possibility of enriching acetylated proteins. The development of such antibodies provides a valuable tool for detecting acetylation, but this approach is also complicated by the extremely high abundance of some acetylated proteins, such as histones and tubulin, in the cell. Thus, the abundant acetylation of histone and tubulin hinders the detection of acetylation of low-abundance proteins.
Kim et al. 10 developed a method of coupling anti-acetyllysine affinity purification to mass spectrometry (MS). By enriching acetylated peptides through affinity purification and reducing interference from high-abundance acetylated histone peptides through subcellular fractionation, Kim et al. 10 successfully detected many low-abundance acetylated peptides. Further improvement of this approach resulted in two recent proteomic studies, one from our group 11 and the other from Choudhary et al. 12 . Whereas Kim et al. 10 identified close to 200 acetylated proteins from mouse liver, our improved approach has identified more than 1,000 acetylated proteins from human liver 11 . The substantially higher number of acetylated proteins identified in our study may be attributed to the high affinity of our homemade anti-acetyllysine, as well as to the fact that we have carried out multiple rounds of identification procedures to ensure more comprehensive coverage. Our number is similar to that of Choudhary et al. 12 , who identified more than 1,000 acetylated proteins from a human leukemia cell line. These studies, taking similar approaches, have substantially expanded our knowledge of the acetylome and functions of protein acetylation.
The protocols presented here provide detailed information about the generation of pan-acetyllysine and site-specific acetyllysine antibodies, as well as about procedures for subcellular fractionation and affinity enrichment of acetylated peptides from human liver tissue (Fig. 1) . This approach should be applicable to protein acetylation studies in other tissues and organisms.
Experimental design and considerations
The protocol described in this article is based on subcellular fractionation and anti-acetyllysine affinity purification of digested total peptide mixtures, followed by MS. Key factors for the success of this approach include the specificity and affinity of anti-acetyllysine, the accessibility of acetylated lysine residues, the separation of different cellular fractions and the quality of MS analyses. The low affinity of most antibodies to acetyllysine means that they are ineffective in precipitating whole protein even if the protein is acetylated.
Moreover, the acetylated lysine residue may be buried inside a protein and not accessible to antibody binding. These problems can be solved by trypsin digestion. The acetylated peptides generated by protease digestion are much smaller than a whole protein and can be immunoprecipitated by anti-acetyllysine even if the antibody has low affinity. Furthermore, acetylated lysine residues will be readily accessible to the antibody because digested peptides lack secondary structure. To avoid interference by highly abundant acetylated proteins such as histone, cell fractionation can be used to separate the nucleus from other organelles or cytosol.
The lack of polarity and the unique steric structure of the acetyl group lead to it offering very few useful chemical and physical properties that can be used to enrich acetylated proteins. Therefore, antibody-based affinity purification offers an attractive approach to identifying acetylated proteins. However, the small acetyl group (42 Da) also has low antigenicity, and it is thus challenging to generate a high-affinity antibody. Antigens used to generate antibodies to acetyllysine are usually either acetyllysine-containing synthetic peptides or chemically acetylated carrier proteins 13 . The benefits of using chemically acetylated carrier protein as antigen are twofold: first, there are many acetyllysine residues in one carrier protein, which is likely to increase the chance of obtaining anti-acetyllysine antibody and, second, the flanking sequences of each acetyllysine residue vary greatly, according to the carrier protein's sequence, making it possible to generate an anti-acetyllysine pool that can recognize acetyllysine independent of flanking sequences. This is particularly important for isolation of total cellular acetylated peptides, given that lysine acetylation sites have minimal consensus sequence. Lysine ε-amino group acetylation can be easily carried out by a single-step chemical reaction using acetic anhydride 13 , making it simple in practice to obtain sufficient antigen.
Interference caused by the high abundance of some acetylated proteins during enrichment can be resolved, at least in part, by subcellular fractionation. For example, the highly abundant histones are mainly in the nuclear fraction and can be easily separated from other subcellular compartments by centrifugation. Mitochondrial proteins are now known to be extensively acetylated 14 . Because intact mitochondria can be readily separated from the cytosolic fraction by centrifugation, mitochondrial proteins can be enriched and analyzed separately without the interference of cytoplasmic proteins, such as the highly abundant and heavily acetylated tubulin 15, 16 .
MS analyses of separate subcellular fractions also greatly reduce the complexity of each fraction, thereby increasing the coverage of acetylated peptide identification. By these manipulations, we expect to detect more acetylated proteins, especially the low-abundance ones. Compared with directly analyzed acetylated peptides in samples, which usually yield 1%-2% positive hits among the total peptides detected, affinity-enriched samples should yield a much higher percentage of positive hits. In addition, as a single round of manipulation usually results in insufficient coverage, experiments will need to be repeated 3-4 times to ensure the identification of a large number of acetylated peptides and thus to define a comprehensive acetylome [10] [11] [12] .
Comments regarding the procedure. Acetylated BSA was used to analyze pan-anti-acetyllysine specificity. It was generated using the same protocol from Steps 1 to 10, except that ovalbumin (OVA) was replaced by BSA. Wet-transfer chamber (Bio-Rad; for western blotting) Power supply (500 V, 500 mA, SDS-PAGE; Bio-Rad) 2| Add 100 µl of acetic anhydride slowly while shaking gently.  crItIcal step Acetic anhydride needs to be added dropwise with constant shaking to avoid precipitation of OVA. It takes ~10 min to complete this step. 
5|
Add 400 µl of 1 M Tris base into the reaction mixture to stop the reaction.
6| Load 2 ml of reaction mixture to a 10-ml Sephadex G-25 gel filtration column and remove organic reagents by running the reaction mixture through the column with 50 mM Tris buffer in an AKTA-FPLC system; monitor optical density at 280 nm (OD 280 ) to collect the eluted protein.  crItIcal step Pyridine has absorbance at 280 nm and it runs out of the column right after the protein peak. ? trouBlesHootInG 7| Repeat Step 6 until the entire reaction mixture is separated and acetylated OVA is collected.
8| Vacuum-dry acetylated OVA overnight in a concentrator (Eppendorf 5301).  pause poInt Dried acetylated protein can be stored at 4 °C until it is needed for the next step.
9|
Prepare SDS-PAGE samples by dissolving both acetylated and unacetylated OVA in 1 ml of 5× SDS loading buffer (prepared as described in the table below); heat at 99 °C for 5 min. 10| Run unacetylated and acetylated OVA in 10% (wt/vol) SDS gel (prepared as described in the table below) and check molecular weight gain of acetylated OVA to verify sufficient acetylation of OVA (Fig. 2) . . Note: For generation of site-specific acetyllysine antibody, use the same protocol from Steps 11-24; see Box 1 for preparation of antigen to Lys288-acetylated argininosuccinate lyase 11 .
12| Mix the antigen solution and complete Freund's adjuvant (1:1, vol/vol).
13| Inject 1 ml of mixed antigen into a New Zealand rabbit subcutaneously (s.c.) in multiple places; antigen dosage should be 200-400 µg per rabbit. 
17|
Obtain the blood sample (1 ml) from rabbit ear and determine antibody titer (Box 3).
Days 88-90 (perform these steps on any day during this time period) 18| Boost immunization again by injecting rabbits with boost antigen at 100-200 µg per rabbit s.c.  pause poInt Wait 10-15 days after final immunization to kill the rabbit and continue the procedure.
19| 10-15 days after final immunization, kill the rabbit and collect blood (~50 ml per rabbit) from the carotid arteries.
20|
Place collected blood in a 37 °C incubator for 2 h.
21|
Transfer blood from 37 °C to 4 °C and maintain at 4 °C overnight.  pause poInt Store blood at 4 °C overnight before continuing to the next step.
22|
The next day, centrifuge blood at 6,000g at 4 °C for 20 min.
23|
Carefully collect antiserum and discard pellets. 
32|
Retain the supernatant and discard the pellet.
33|
Quantify total protein in the supernatant using Bradford reagent.
34|
Run treated and control samples with an equal amount of total proteins on a 12% (wt/vol) SDS gel.
sDs gel (12%) component ml 38| Incubate the membrane with pan-anti-acetyllysine antibody (titer 1:100,000) diluted at 1:500 (vol/vol) in 10 ml of peptone-antibody buffer (prepared according to the in-text table below), shaking at room temperature for 4-6 h. The dilution factor varies among different batches of antiserum.
39|
Wash the membrane three times with TBST buffer.
40|
Incubate the membrane with secondary antibody diluted at 1:1,000 (vol/vol) in 10 ml peptone-antibody buffer, along with shaking at room temperature for 2-3 h.
peptone-antibody buffer component concentration
Tris-HCl (pH 7. 
44|
Mince the tissue into small pieces with a razor blade and scissors.  crItIcal step This and the following steps (Steps 44-51) must be performed on ice.
45|
Transfer minced tissue to a 10 ml glass Dounce homogenizer (on ice) and add 5 ml of ice-cold homogenization buffer. 47| Pass homogenized mixture through a 100-mm-diameter cell filter (pore size 125 µm) to remove debris.
Homogenization buffer component concentration

KCl
48|
Centrifuge the filtered mixture at 1,000g at 4 °C for 10 min.
49|
Carefully transfer the supernatant to another centrifuge tube and retain the pellet. Note that pellets contain nuclei; see Box 4 for extraction of nuclear proteins.
50|
Centrifuge at 10,000g at 4 °C for 30 min. 53| Add freshly prepared iodoacetamide to the protein solution to a final concentration of 15 mM to modify SH groups; allow the reaction to proceed in the dark at room temperature for 30 min.
54| Add cysteine to a final concentration of 15 mM to stop the reaction; allow the reaction to proceed at room temperature for 30 min.
55|
Add chilled acetone to the solution to reach a final concentration of 85% (vol/vol).
56|
Store the solution at − 20 °C for 1 h to allow complete precipitation of proteins.
57|
Centrifuge at 800g at 4 °C for 15 min and discard the supernatant.  crItIcal step In Steps 57 and 58, do not exceed 800g each time in order to avoid solubility problems caused by tight pellet formation. ? trouBlesHootInG 58| Wash the pellet three times with 5 ml of chilled acetone by thoroughly mixing and then centrifuge it at 800g at 4 °C for 5 min.
? trouBlesHootInG 59| Vacuum-dry protein pellets with a vacuum concentrator (Eppendorf 5301) for ~30 min.
60|
Dissolve the protein pellet in 5 ml of 50 mM NH 4 HCO 3 (pH 8.0) and sonicate for 5 min at room temperature to increase solubility.  crItIcal step Turbidity in the solution may be observed at this point. Do not centrifuge to remove it; use it directly for the following steps.
61|
Determine the protein concentration of the suspension by the Bradford method.
62|
In a fresh tube, take 3-10 mg protein, add sequencing-grade trypsin at a 1:50 (trypsin:protein) ratio, and hydrolyze at 37 °C overnight.  crItIcal step Although the reaction solution becomes clear after ~1 h, continue the digestion process overnight. 63| Add additional trypsin to the tube at a ratio of 1:100 (trypsin:protein) and incubate for 3 h at 37 °C.
64|
Heat the sample at 99 °C for 5 min to inactivate trypsin.
65|
Centrifuge at 12,000g for 10 min; retain the supernatant and discard the pellet (mainly contains insoluble proteins).
66|
Vacuum-dry the supernatant and redissolve the pellet in 1 ml of deionized water.
67| Repeat
Step 66 three to four times.  crItIcal step Steps 66 and 67 remove NH 4 CO 3 ; repeat several more times if a large amount of white powder is detected in the tube.
68|
Redissolve the pellet in 1.5 ml of NETNA binding buffer. 
71|
Centrifuge at 1,000g briefly ( < 10 s) and carefully remove the supernatant.
72|
Wash beads three times with 1 ml of PBS buffer.
73|
Remove PBS buffer completely and add 150 µl of elution buffer. ? trouBlesHootInG Generation of chemical acetylated antigen step 3: Precipitation usually causes low efficiency of acetylation of carrier proteins and subsequently leads to inability to generate high-quality anti-acetyllysine antibody. Although acetic anhydride and pyridine are both used in chemical acetylation processes, excess amounts of both reagents or inappropriate addition of either reagent to the reaction solution can cause protein precipitation. Each component should be added to the reaction solution according to the specified order. If precipitation is still observed during the reaction, reduce the initial OVA concentration to half of that indicated in the protocol. step 6: It is essential to separate pyridine and acetic acid from acetylated OVA to ensure purity of the antigen. We used a 10-ml Sephadex G-25 column loaded with 2 ml of reaction mixture to separate acetylated OVA from pyridine and acetic acid on an AKTA-FPLC system. A longer column may be needed if the separation is incomplete.
treatment of cells by deacetylase inhibitors steps 27 and 28: When it comes to prepare cells for anti-acetyllysine antibody verification, successful treatment by deacetylase inhibitors is critical to the preparation of cells for anti-acetyllysine antibody verification, as unsuccessful treatment could lead to incorrect conclusions. Of the three classes of deacetylases identified in cells so far, class I and II deacetylases are successfully inhibited by 0.5 µM trichostatin A treatment and NAD + -dependent sirtuins are inhibited by 5 mM nicotinamide (NAM) treatment. In our system, the effect of trichostatin A treatment is obvious after treating cells for 18 h; NAM treatment, however, exerts the strongest effect when cells are treated for 4-6 h. A time-course experiment may be needed to determine appropriate timing for optimal inhibition results.
avoid formation of insoluble protein pellet steps 57 and 58: Acetone precipitated proteins have the advantage of being easily re-dissolved in a water-based solution. However, if the precipitated proteins are in a tightly packed pellet, it is hard for all proteins to redissolve, thus affecting the completion of trypsin digestion. Once a tight pellet is formed, it is helpful to add 1 ml of acetone to the pellet and to follow this with sonication for 5-10 min to break up the pellet; thereafter, vacuum-dry to remove acetone. The resulting protein pellet powder is easy to dissolve in NH 4 CO 3 solution.
Increase solubility of acetylated peptides step 68: After proteins have been digested into peptides, hydrophobic ones cannot be easily dissolved in aqueous buffer. This is particularly important for acetylated peptides because acetylation changes a positively charged lysine residue to a neutral acetyllysine, thus inevitably decreasing the solubility of acetylated peptides. Addition of acetonitrile to the buffer can increase the solubility of hydrophobic peptides (Step 68) because acetonitrile is a good solution for hydrophobic peptides but has little effect on antibody stability 17 , thus facilitating enrichment of acetylated peptides. However, the concentration of acetonitrile in the buffer should not exceed 20% because it will denature the antibody at a high concentration.
antIcIpateD results
Chemical acetylation of proteins typically results in addition of acetyl groups to lysine residues stoichiometrically. Acetylated proteins thus have higher molecular weight compared with unacetylated protein when resolved in SDS-PAGE (Fig. 2) . After antibody is generated, the quality of the antibody can be tested with cell lysates treated with or without deacetylase inhibitors. Typically, acetylation of prominent bands, such as histone or tubulin, should be elevated on inhibitor treatment 11 . As the antigen is acetylated OVA, antibodies against OVA backbone can also be generated. The specificity of the antibody can be tested using acetylated BSA as competitor 11 . The process of acetylated enrichment is hard to follow; however, the amount of enriched peptides can be monitored when samples are run through liquid chromatography (Fig. 3) . The successful enrichment of acetylated peptides can be judged by assessing whether acetylated histone peptides are identified by tandem MS analysis. Typically, identification of various acetylated histone peptides indicates a successful enrichment (Fig. 4) . A more meaningful measurement is the percentage of acetylated peptide over total peptides identified. Without antibody purification, acetylated peptides normally represent < 2% of the total liver peptides. In our studies, acetylated peptides usually account for 10-20% of the total enriched peptides. Finally, clean MS/MS spectra for acetylated peptides of non-nuclear proteins indicate a successful enrichment of such proteins (Fig. 5) . 
